Liquidia Technologies Signs Lease for New Facility

Liquidia Technologies ( (LQDA) ) has shared an update.

On June 16, 2025, Liquidia Technologies entered into a lease agreement for a new manufacturing facility in Morrisville, North Carolina, with King Combs LLC. The lease, which spans approximately 70,131 square feet, will commence on June 16, 2025, and expire on November 1, 2036, with options for extension. The agreement includes a monthly base rent starting at $260,069.13 from May 1, 2026, with a 3% annual increase, and a six-month rent abatement period. This move is expected to enhance Liquidia’s manufacturing capabilities and potentially expand its operational footprint.

The most recent analyst rating on (LQDA) stock is a Buy with a $29.00 price target. To see the full list of analyst forecasts on Liquidia Technologies stock, see the LQDA Stock Forecast page.

Spark’s Take on LQDA Stock

According to Spark, TipRanks’ AI Analyst, LQDA is a Neutral.

Liquidia’s overall stock score is primarily impacted by its financial struggles, with significant debt and ongoing losses being major concerns. However, the recent FDA approval and favorable legal outcomes for YUTREPIA offer hope for future growth. Technical indicators are neutral, and the lack of profitability affects valuation.

To see Spark’s full report on LQDA stock, click here.

More about Liquidia Technologies

Liquidia Technologies, Inc., a wholly owned subsidiary of Liquidia Corporation, operates in the biotechnology industry, focusing on developing and manufacturing pharmaceutical products.

Average Trading Volume: 1,861,413

Technical Sentiment Signal: Buy

Current Market Cap: $1.2B

For a thorough assessment of LQDA stock, go to TipRanks’ Stock Analysis page.